Results 161 to 170 of about 44,954 (187)

Preparation and Inactivation of Purified Poliovirus: Comparison of Vaccines Derived from Mahoney and Parker Poliovirus

Experimental Biology and Medicine, 1957
W. P. Fisher, Jesse Charney, Roy A. Machlowitz   +2 more
openaire   +3 more sources

Eliminating all circulating vaccine-derived poliovirus: a prerequisite to declaring global polio eradication. [PDF]

Int Health, 2023
Durrheim DN.
europepmc   +1 more source

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023. [PDF]

MMWR Morb Mortal Wkly Rep, 2023
Davlantes E, Jorba J, Henderson E, Bullard K, Deka MA, Kfutwah A, Martin J, Bessaud M, Shulman LM, Hawes K, Diop OM, Bandyopadhyay AS, Zipursky S, Burns CC.   +13 more
europepmc   +1 more source

Re-emergence of vaccine-derived poliovirus in Israel, US, and UK - Call for promoting the use of novel oral polio vaccine. [PDF]

Ann Med Surg (Lond), 2022
Shahnoor S, Ghaffar R, Taimuri MA.
europepmc   +1 more source

Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study.

The Lancet Microbe
N. Zuckerman, E. Bucris, Hagar Morad-Eliyahu, L. Weiss, Rinat Vasserman, I. Fratty, Irina Aguvaev, Zvi Cohen-Said, Rua Matar, O. Erster, L. Shulman, Ruth Yishai, Lior Hecht-Sagie, Sharon Alroy-Preis, Ella Mendelson, Y. Lustig, D. Sofer, Itay Bar-Or, M. Weil   +18 more
semanticscholar   +1 more source

Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria.

Vaccine, 2022
L. Lorenzetti, Rustam Haydarov, E. Namey, Anna Lawton, Hayon Nam, Muhamad Ridwan Hasan, Claude Monj, Surangani Abeyesekera, Maria Amina Kabwau, Ross Mcintosh   +9 more
semanticscholar   +1 more source

Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication [PDF]

, 2001
Pedro Más Lago, Victor M. Cáceres, Miguel A. Galindo, Howard E. Gary, Marlen Valcárcel, Julio César Quiroz Barrios, Luís Sarmiento, Ivonee Avalos, J Bravo, Rosa Palomera, M Bello, Roland W. Sutter, Mark A Pallansch, Ciro A. de Quadrós   +13 more
openalex   +1 more source

Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia [PDF]

, 2004
Soile Blomqvist, Carita Savolainen, Pia Laine, Päivi Hirttiö, Elisa Lamminsalo, Eija Penttilä, Silver Jöks, Merja Roivainen, Tapani Hovi   +8 more
openalex   +1 more source

The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies. [PDF]

Int J Surg
Mohapatra RK, Kutikuppala LVS, Seidel V, Ansari A, Mishra S, Mishra S, Kandi V.   +6 more
europepmc   +1 more source

Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication [PDF]

, 2006
Radboud J. Duintjer Tebbens, Mark A. Pallansch, Olen M. Kew, Victor M. Cáceres, Hamid Jafari, Stephen L. Cochi, Roland W. Sutter, R. Bruce Aylward, Kimberly M. Thompson   +8 more
openalex   +1 more source